Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RIVN vs GSK✓SelectedUSD · GSKRIVN vs GSK performance historyLatest closeAs of-0.66%11/16
Stock and ETF performance explorer

RIVN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-93.0%
GSK return
+46.9%
Excess return
-139.9%
Maximum drawdown
-95.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.6%
7D-13.6%-1.3%-12.3%-13.5%
30D-2.6%+2.7%-5.3%-2.9%
3M-21.2%+2.7%-23.9%-21.5%
6M-12.3%+3.3%-15.6%-12.8%
YTD-38.6%+6.5%-45.1%-39.3%
1Y-19.9%+10.7%-30.6%-21.2%
3Y-26.2%+64.4%-90.5%-32.6%
5Y-93.0%+46.7%-139.7%-95.0%
All-93.0%+46.9%-139.9%-95.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling